Pleasantville, NY, United States of America

Viktoria Gusarova

This inventor holds 17 USPTO granted patents and 19 published patent applications, plus 4 CIPO patents and 9 EPO patents, primarily in Biopharmaceutical Research. Top assignees: Regeneron Pharmaceuticals, Inc., Sanofi Biotechnology. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Viktoria Gusarova. Retrieved from https://idiyas.com/inventor/viktoria-gusarova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 19)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 8)

EPO Patents = 9 (Patent Applications = 19)

Average Co-Inventor Count = 4.2

ph-index = 4

Forward Citations = 57(Granted Patents)

Location History:

Springfield, NJ (US) (2013 - 2015)
Tarrytown, NY (US) (2019 - 2021)
Pleasantville, NY (US) (2015 - 2024)

Company Filing History:

17 out of 1,488

Regeneron Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

Anti-ANGPTL3 Antibodies

PCSK9 Inhibitors

LXR Agonists

Hyperlipidemia Treatment

Atherosclerosis Inhibition

Humanized ASGR1 Locus

ANGPTL8 Assay

Obesity Treatment

Non-Human Animals

Protein Conjugates

Human Angiopoietin-Like Protein

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12680107 - NON-HUMAN ANIMALS COMPRISING A HUMANIZED ASGR1 LOCUS (2026-07-14),

2. 12497460 - ANTI-MSR1 ANTIBODIES AND METHODS OF USE THEREOF (2025-12-16),

3. 12281173 - Methods for treating patients with hyperlipidemia by administering a PCSK9 inhibitor in combination with an ANGPTL3 inhibitor (2025-04-21),

4. 12209180 - Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof for use as LXR agonists (2025-01-28),

5. 11977081 - ANGPTL8 assay and uses thereof (2024-05-07),

6. 11696572 - Non-human animals comprising a humanized ASGR1 locus (2023-07-11),

7. 11377502 - Anti-MSR1 antibodies and methods of use thereof (2022-07-05),

8. 10995150 - Methods for inhibiting atherosclerosis by administering an anti-PCSK9 antibody (2021-05-04),

9. 10582702 - Non-human animals having an engineered ANGPTL8 gene (2020-03-10),

10. 10494442 - Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9 (2019-12-03),

11. 10442856 - Methods of treating obesity with anti-ANGPTL8 antibodies (2019-10-15),

12. 10358487 - Anti-ANGPTL3 antibodies and uses thereof (2019-07-23),

13. 10259870 - Anti-ANGPTL8 antibodies and uses thereof (2019-04-16),

14. 9951127 - Anti-ANGPTL3 antibodies and uses thereof (2018-04-24),

15. 9120851 - Human antibodies to human angiopoietin-like protein 4 (2015-09-01),

Title: The Innovative Journey of Inventor Viktoria Gusarova

Introduction: Viktoria Gusarova is a pioneering inventor based in Pleasantville, NY, known for her groundbreaking contributions to various fields.

Latest Patents: Viktoria Gusarova's recent patents include advancements in renewable energy technology, sustainable packaging solutions, and medical device innovations.

Career Highlights: With a career spanning over two decades, Viktoria Gusarova has established herself as a leading figure in the world of innovation. Her work has been recognized globally for its impact on improving lives and shaping industries.

Collaborations: Throughout her career, Viktoria Gusarova has collaborated with top research institutions, universities, and companies to bring her inventions to life. Her partnerships have led to the development of cutting-edge technologies that have revolutionized their respective fields.

Conclusion: Viktoria Gusarova's relentless pursuit of innovation and her passion for creating positive change through her inventions continue to inspire the next generation of inventors. Her dedication to pushing the boundaries of what is possible serves as a testament to the power of creativity and perseverance in driving progress.

Profile summary based on public USPTO records.